Hereditary leiomyomatosis and renal cell cancer syndrome associated renal cell carcinoma

被引:2
|
作者
Adamane, Shraddha [1 ]
Desai, Sangeeta [1 ]
Menon, Santosh [1 ]
机构
[1] Tata Mem Hosp, Dept Pathol, 8th Floor,Annexe Bldg, Bombay 400012, Maharashtra, India
关键词
Hereditary; immunohistochemistry; leiomyomatosis; renal; HOGG-DUBE-SYNDROME; KIDNEY TUMORS; MUTATIONS; GERMLINE;
D O I
10.4103/0377-4929.200025
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a recently described entity with unknown exact prevalence. The affected individuals are predisposed to have multiple leiomyomas and renal cancer due to germline mutation in fumarate hydratase gene on chromosome 1. The knowledge of this rare tumour is essential for early recognition and institution of appropriate therapy, since they have a grave prognosis. Herein, we present the first case from India of HLRCC in a 42 year old lady who presented with a renal mass and metastasis with consequent fulminant course of disease. We discuss the detailed histomorphologic features and iunique immunohistochemical signature of this unusual renal tumour with discussion of differential diagnosis.
引用
收藏
页码:108 / 110
页数:3
相关论文
共 50 条
  • [41] Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma
    Guinard, Elisabeth
    Legendre, Laureline
    Kramkimel, Nora
    Avril, Marie Francoise
    Chassaing, Nicolas
    Cabaret, Odile
    Guillaud-Bataille, Marine
    Hautier, Juliette Mazereeuw
    DERMATOLOGY, 2016, 232 (03) : 293 - 297
  • [42] Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
    Kerins, Michael J.
    Milligan, John
    Wohlschlegel, James A.
    Ooi, Aikseng
    CANCER SCIENCE, 2018, 109 (09): : 2757 - 2766
  • [43] Identifying Hereditary Leiomyomatosis and Renal Cell Cancer through Unobtrusive Cutaneous Nodules: A Clinical Report
    Sestokaite, Emilija
    Preiksaitiene, Egle
    Arasimavicius, Justas
    JOURNAL OF KIDNEY CANCER AND VHL, 2025, 12 (01): : 1 - 4
  • [44] Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
    Chan, Emily
    Rabban, Joseph T.
    Mak, Julie
    Zaloudek, Charles
    Garg, Karuna
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (09) : 1170 - 1179
  • [45] Management of renal cell carcinoma in young patients and patients with hereditary syndromes
    Leung, Cynthia
    Pan, Shu
    Shuch, Brian
    CURRENT OPINION IN UROLOGY, 2016, 26 (05) : 396 - 404
  • [46] Utility of Prospective Pathologic Evaluation to Inform Clinical Genetic Testing for Hereditary Leiomyomatosis and Renal Cell Carcinoma
    Kopp, Ryan P.
    Stratton, Kelly L.
    Glogowski, Emily
    Schrader, Kasmintan A.
    Rau-Murthy, Rohini
    Russo, Paul
    Coleman, Jonathan A.
    Offit, Kenneth
    CANCER, 2017, 123 (13) : 2452 - 2458
  • [47] Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review
    Feng, Dalin
    Wang, Mingshuai
    Zhang, Xiaodong
    Wang, Jianwen
    AKTUELLE UROLOGIE, 2021, 52 (01) : 58 - 63
  • [48] Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature
    Shero, Nora
    Yoon, Esther
    Goicoechea, Joel Cardenas
    CASE REPORTS IN WOMENS HEALTH, 2023, 39
  • [49] Postmortem genetic diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome: Identification through normal kidney tissues after surgical removal
    Suzuki, Shodai
    Yamamoto, Yoshiyuki
    Kato, Taigo
    Hatano, Koji
    Matsui, Takahiro
    Hashimoto, Kae
    Miyamura, Takako
    Nagashima, Yoji
    Nonomura, Norio
    Kawashima, Atsunari
    IJU CASE REPORTS, 2025, 8 (02) : 109 - 113
  • [50] Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
    van Spaendonck-Zwarts, Karin Y.
    Badeloe, Sadhanna
    Oosting, Sjoukje F.
    Hovenga, Sjoerd
    Semmelink, Harry J. F.
    van Moorselaar, R. Jeroen A.
    van Waesberghe, Jan Hein
    Mensenkamp, Arjen R.
    Menko, Fred H.
    FAMILIAL CANCER, 2012, 11 (01) : 123 - 129